Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mihara

Showing results (171-180 of 211) with videos related to

Pageof 22
Sort By:
Leukemia|February 13, 2004
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemiaC Imai, K Mihara, M Andreansky, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 16, 2001
Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary reportA Suzuki, T Kondo, K Mihara, et al.
American Journal of Medical Genetics|May 16, 2001
Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidolK Mihara, A Suzuki, T Kondo, et al.
British Journal of Haematology|December 1, 1995
High proportions of VLA-5- immature myeloma cells correlated well with poor response to treatment in multiple myelomaM M Kawano, M S Mahmoud, N Huang, et al.
British Journal of Pharmacology|December 21, 2013
Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory diseaseM D Hollenberg, K Mihara, D Polley, et al.
Acta Medica Okayama|November 14, 1997
Yeast functional assay of the p53 gene status in human cell lines maintained in our laboratoryK Mihara, M Miyazaki, T Kondo, et al.
Therapeutic Drug Monitoring|February 1, 1997
Increases in plasma concentration of m-chlorophenylpiperazine, but not trazodone, with low-dose haloperidolK Mihara, K Otani, M Ishida, et al.
Journal of Medical Virology|February 1, 1996
Persistence of hepatitis C virus RNA in established human hepatocellular carcinoma cell linesS Tsuboi, S Nagamori, M Miyazaki, et al.
Journal of Cell Science|December 12, 2001
Direct targeting of cis-Golgi matrix proteins to the Golgi apparatusS I Yoshimura, N Nakamura, F A Barr, et al.
Blood|March 27, 2001
Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemiaJ S Chen, E Coustan-Smith, T Suzuki, et al.
Pageof 22

Showing results (171-180 of 211) with videos related to

Sort By:
Pageof 22
Leukemia|February 13, 2004
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemiaC Imai, K Mihara, M Andreansky, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 16, 2001
Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary reportA Suzuki, T Kondo, K Mihara, et al.
American Journal of Medical Genetics|May 16, 2001
Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidolK Mihara, A Suzuki, T Kondo, et al.
British Journal of Haematology|December 1, 1995
High proportions of VLA-5- immature myeloma cells correlated well with poor response to treatment in multiple myelomaM M Kawano, M S Mahmoud, N Huang, et al.
British Journal of Pharmacology|December 21, 2013
Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory diseaseM D Hollenberg, K Mihara, D Polley, et al.
Acta Medica Okayama|November 14, 1997
Yeast functional assay of the p53 gene status in human cell lines maintained in our laboratoryK Mihara, M Miyazaki, T Kondo, et al.
Therapeutic Drug Monitoring|February 1, 1997
Increases in plasma concentration of m-chlorophenylpiperazine, but not trazodone, with low-dose haloperidolK Mihara, K Otani, M Ishida, et al.
Journal of Medical Virology|February 1, 1996
Persistence of hepatitis C virus RNA in established human hepatocellular carcinoma cell linesS Tsuboi, S Nagamori, M Miyazaki, et al.
Journal of Cell Science|December 12, 2001
Direct targeting of cis-Golgi matrix proteins to the Golgi apparatusS I Yoshimura, N Nakamura, F A Barr, et al.
Blood|March 27, 2001
Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemiaJ S Chen, E Coustan-Smith, T Suzuki, et al.
Pageof 22